Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects
Clinical trial NCT04707768 · COMPLETED
Trial details
- NCT number
- NCT04707768
- Sponsor
- Akebia Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-18
- Primary completion
- 2023-01-06
- Enrollment
- 456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.